Unraveling the enigma: elucidating the relationship between the physicochemical properties of aluminium-based adjuvants and their immunological mechanisms of action

by Emma Shardlow, Matthew Mold, Christopher Exley
Published 2018-11-01

Aluminium in Brain Tissue in Epilepsy: A Case Report from Camelford

by Matthew Mold, Jason Cottle, Christopher Exley
Published 2019-06-01

Intracellular Aluminium in Inflammatory and Glial Cells in Cerebral Amyloid Angiopathy: A Case Report

by Matthew Mold, Jason Cottle, Andrew King, Christopher Exley
Published 2019-04-01

Intracellular tracing of amyloid vaccines through direct fluorescent labelling

by Matthew Mold, Manpreet Kumar, Ambreen Mirza, Emma Shardlow, Christopher Exley
Published 2018-02-01

Aluminium in Brain Tissue in Multiple Sclerosis

by Matthew Mold, Agata Chmielecka, Maria Raquel Ramirez Rodriguez, Femia Thom, Caroline Linhart, Andrew King, Christopher Exley
Published 2018-08-01

CERTL reduces C16 ceramide, amyloid-β levels, and inflammation in a model of Alzheimer’s disease

by Simone M. Crivelli, Qian Luo, Jo A.A. Stevens, Caterina Giovagnoni, Daan van Kruining, Gerard Bode, Sandra den Hoedt, Barbara Hobo, Anna-Lena Scheithauer, Jochen Walter, Monique T. Mulder, Christopher Exley, Matthew Mold, Michelle M. Mielke, Helga E. De Vries, Kristiaan Wouters, Daniel L. A. van den Hove, Dusan Berkes, María Dolores Ledesma, Joost Verhaagen, Mario Losen, Erhard Bieberich, Pilar Martinez-Martinez
Published 2021-02-01